IMC Chicago’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$419K Sell
127,500
-47,300
-27% -$158K ﹤0.01% 5132
2026
Q2
$503K Buy
174,800
+3,100
+2% +$7.88K ﹤0.01% 4834
2026
Q1
$337K Buy
171,700
+80,100
+87% +$188K ﹤0.01% 4691
2025
Q4
$248K Buy
91,600
+33,200
+57% +$109K ﹤0.01% 4093
2025
Q3
$247K Buy
58,400
+13,000
+29% +$57.1K ﹤0.01% 3625
2025
Q2
$226K Sell
45,400
-3,100
-6% -$13.5K ﹤0.01% 3386
2025
Q1
$214K Buy
+48,500
New +$228K ﹤0.01% 3193

Other funds holding GDRX

IMC Chicago's GDRX Position: Q3 2026 in Review

IMC Chicago increased its GoodRx Holdings (GDRX) stake by 35% in Q3 2026, buying an estimated $42.1K and bringing the position to 48,891 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #6143.

IMC Chicago first reported a position in GDRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $392K in Q2 2025. 183 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • IMC Chicago held 48,891 shares of GoodRx Holdings worth $161K as of Q3 2026.
  • IMC Chicago bought 12,641 GoodRx Holdings shares in Q3 2026, an estimated $42.1K.
  • GoodRx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #6143 holding.
  • IMC Chicago first reported a position in GoodRx Holdings in Q4 2024 and has held it in 8 quarters since.
  • IMC Chicago's GoodRx Holdings position peaked at $392K in Q2 2025.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.